Driehaus Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Driehaus Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-437,123	Closed	-$15.3M	–	419
2024 Q2	$15.3M	Sell	437,123 -4,807	-1%	-$190K	0.15%	180
2024 Q1	$19.4M	Sell	441,930 -470,856	-52%	-$20.2M	0.19%	152
2023 Q4	$32.5M	Buy	912,786 +215,325	+31%	+$6.43M	0.39%	71
2023 Q3	$18.8M	Buy	697,461 +435,025	+166%	+$11M	0.24%	134
2023 Q2	$6.17M	Buy	+262,436	New	+$5.4M	0.08%	261
2020 Q3	–	Sell	-106,009	Closed	-$1.51M	–	412
2020 Q2	$1.51M	Sell	106,009 -68,074	-39%	-$536K	0.04%	272
2020 Q1	$717K	Hold	174,083	–	–	0.02%	280
2019 Q4	$1.31M	Hold	174,083	–	–	0.03%	292
2019 Q3	$1.57M	Hold	174,083	–	–	0.05%	271
2019 Q2	$1.73M	Buy	+174,083	New	+$1.89M	0.05%	242

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Driehaus Capital Management's IDYA Position: Q3 2024 in Review

Driehaus Capital Management sold out of IDEAYA Biosciences (IDYA) in Q3 2024, closing a stake of 437,123 shares — an estimated $15.3M sold.

Driehaus Capital Management first reported a position in IDYA in Q2 2019 and held it in 10 quarters. The position peaked at $32.5M in Q4 2023. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

Driehaus Capital Management reported no remaining IDEAYA Biosciences position as of Q3 2024 after selling out during the quarter.
Driehaus Capital Management sold 437,123 IDEAYA Biosciences shares in Q3 2024, an estimated $15.3M.
Driehaus Capital Management first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 10 quarters.
Driehaus Capital Management's IDEAYA Biosciences position peaked at $32.5M in Q4 2023.
209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on Driehaus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.